Literature DB >> 6525175

Complement-component-C3-opsonized immunoglobulin G anti-DNA antibodies do not bind effectively to red blood cells unless aggregated on a high-Mr DNA matrix.

C Horgan, R P Taylor.   

Abstract

Large, soluble ds (double-stranded) DNA-IgG (immunoglobulin G) anti-dsDNA immune complexes (greater than or equal to 200 S) that were previously opsonized with complement were digested with DNAase. The small complement-component-C3-fragment-labelled IgG (11-14 S) that was then isolated did not bind effectively to complement receptor type 1 on human red blood cells. However, when this IgG was immune-complexed with 3H-labelled PM2 (bacteriophage directed against a marine Pseudomonas) dsDNA (Mr approximately 6 X 10(6), substantial binding of both the DNA antigen and IgG to the erythrocytes was demonstrable.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6525175      PMCID: PMC1144510          DOI: 10.1042/bj2240755

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

1.  C3 receptors, complement deficiency and SLE.

Authors:  M Walport; P Lachmann
Journal:  Br J Rheumatol       Date:  1984-02

2.  Low ionic strength or chemical cross-linking of monomeric C3b increases its binding affinity to the human complement C3b receptor.

Authors:  M A Arnaout; N Dana; J Melamed; R Medicus; H R Colten
Journal:  Immunology       Date:  1983-02       Impact factor: 7.397

3.  The complement-mediated binding of soluble antibody/dsDNA immune complexes to human neutrophils.

Authors:  R P Taylor; J Burge; C Horgan; D M Shasby
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

4.  Interaction of C3 with antigen-antibody complexes in the process of solubilization of immune precipitates.

Authors:  Y Takata; N Tamura; T Fujita
Journal:  J Immunol       Date:  1984-05       Impact factor: 5.422

5.  Suramin inhibits the binding of complement-fixing antibody/double-stranded DNA immune complexes to CR1.

Authors:  R P Taylor; C Horgan; A Harbin; J Burge
Journal:  Clin Immunol Immunopathol       Date:  1984-11

6.  Studies on the kinetics of binding of complement-fixing dsDNA/anti-dsDNA immune complexes to the red blood cells of normal individuals and patients with systemic lupus erythematosus.

Authors:  C Horgan; R P Taylor
Journal:  Arthritis Rheum       Date:  1984-03

7.  Generation of low m.w., C3-bearing immunoglobulin in human serum.

Authors:  R J Jacobs; M Reichlin
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

8.  Decreased complement mediated binding of antibody/3H-dsDNA immune complexes to the red blood cells of patients with systemic lupus erythematosus, rheumatoid arthritis, and hematologic malignancies.

Authors:  R P Taylor; C Horgan; R Buschbacher; C M Brunner; C E Hess; W M O'Brien; H J Wanebo
Journal:  Arthritis Rheum       Date:  1983-06

9.  Requirement for human red blood cells in inactivation of C3b in immune complexes and enhancement of binding to spleen cells.

Authors:  M E Medof; T Lam; G M Prince; C Mold
Journal:  J Immunol       Date:  1983-03       Impact factor: 5.422

10.  Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes.

Authors:  M E Medof; K Iida; C Mold; V Nussenzweig
Journal:  J Exp Med       Date:  1982-12-01       Impact factor: 14.307

View more
  1 in total

1.  Mechanism of transfer of immune complexes from red blood cell CR1 to monocytes.

Authors:  W Emlen; V Carl; G Burdick
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.